AHA/ACC vs ESC Guidelines for Management of Adults With Congenital Heart Disease: JACC Guideline Comparison.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
09 11 2021
Historique:
received: 13 08 2021
accepted: 04 09 2021
entrez: 5 11 2021
pubmed: 6 11 2021
medline: 4 1 2022
Statut: ppublish

Résumé

The American Heart Association and American College of Cardiology published practice guidelines for the management of adult congenital heart disease in 2018 and the European Society of Cardiology published analogous guidelines in 2020. Although there are broad areas of consensus between the 2 documents, there are important differences that impact patient management. This review discusses key areas of agreement and disagreement between the 2 guidelines, with discussion of possible reasons for disagreement and potential implications.

Identifiants

pubmed: 34736567
pii: S0735-1097(21)06215-X
doi: 10.1016/j.jacc.2021.09.010
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1904-1918

Informations de copyright

Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures Dr Baumgartner was chair of the ESC ACHD guidelines. Dr Stout was chair of the AHA/ACC ACHD guidelines. Drs. Krieger and Valente have received honoraria and travel reimbursement from ACC; and have received travel reimbursement from AHA. Prof Dimopoulos has received honoraria, research, and educational funds from, and acted as a consultant for Janssen. Drs. Valente and Zeppenfeld were coauthors of the AHA/ACC and ESC ACHD guidelines, respectively. Dr Opotowsky has acted as a consultant for Janssen; and serves on an Independent Data Monitoring Committee for Actelion/Johnson & Johnson. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Gabriele Egidy Assenza (G)

Pediatric Cardiology and Adult Congenital Heart Disease Program, Department of Cardio-Thoracic and Vascular Medicine IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Eric V Krieger (EV)

Seattle Adult Congenital Heart Service, Division of Cardiology, Department of Medicine, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.

Helmut Baumgartner (H)

Department of Cardiology III, Division of Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Cardiology, Muenster, Germany.

Blanche Cupido (B)

Cert Cardio (SA): University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa.

Konstantinos Dimopoulos (K)

Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Clauden Louis (C)

Division of Cardiothoracic Surgery, University of Rochester, Rochester, New York, USA.

Adam M Lubert (AM)

Cincinnati Children's Hospital Heart Institute, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Karen K Stout (KK)

Seattle Adult Congenital Heart Service, Division of Cardiology, Department of Medicine, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.

Anne Marie Valente (AM)

Boston Adult Congenital Heart Disease Program, Boston Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Katja Zeppenfeld (K)

Willem Einthoven Center for Cardiac Arrhythmia Research and Management, Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Alexander R Opotowsky (AR)

Cincinnati Children's Hospital Heart Institute, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Electronic address: Sasha.Opotowsky@cchmc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH